Health characteristics of postmenopausal women with breast implants

Plastic and Reconstructive Surgery

Volumn 125, Issue 3, 2010, Pages 799-810

  Rubin, J Peter ^b   Landfair, Angela Song ^b   Shestak, Kenneth ^b   Lane, Dorothy ^b   Valoski, Alice ^b   Chang, Yuefang ^b   Tindle, Hilary A ^b   Kuller, Lewis H ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; BREAST ENDOPROSTHESIS; BREAST TUMOR; FEMALE; GENETICS; HEALTH BEHAVIOR; HEALTH STATUS; HEALTH SURVEY; HUMAN; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; WOMEN'S HEALTH;

ADULT; AGED; BODY MASS INDEX; BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HEALTH STATUS INDICATORS; HUMANS; MIDDLE AGED; OBESITY; POSTMENOPAUSE; QUALITY OF LIFE; WOMEN'S HEALTH;

EID: 77749315006     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181cb5e29     Document Type: Article

References (45)

1. Fock KM, Feng PH. Connective tissue diseases after augmentation mammaplasty. Arthritis Rheum. 1994;27:1440.
2. Fock KM, Feng PH, Tey BH. Autoimmune disease developing after augmentation mammaplasty: Report of 3 cases. J Rheumatol. 1984;11:98-100.
3. Van Nunen SA, Gatenby PA, Basten A. A post-mammaplasty connective tissue disease. Arthritis Rheum. 1982;25:694-697.
4. Weiner SR, Paulus HE. Chronic arthropathy occurring after augmentation mammaplasty. Plast Reconstr Surg. 1986;77: 185-192.
5. Spiera H. Scleroderma after silicone augmentation mammaplasty. JAMA. 1988;260:126-238.
6. Giltay EJ, Moens HJB, Riley AH, Tan RG. Silicone breast prostheses and rheumatic symptoms: A retrospective follow- up study. Ann Rheum Dis. 1994;53:194-196.
7. Jacobsen PH, Holmich LR, McLaughlin JK, et al. Mortality and suicide among Danish women with cosmetic breast implants. Arch Intern Med. 2004;164:2450-2455.
8. FDA News P06-189, Nov. 17, 2006.
9. Silverman BG, Brown SL, Bright RA, Kaczmarek RG, Arrowsmith- Lowe JB, Kessler DA. Reported complications of silicone gel breast implants: An epidemiologic review. Ann Intern Med. 1996;124:744-756.
10. Gabriel SE, O'Fallen WM, Kurland LT, Beard CM, Woods JE, Melton LJ. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med. 1994;330: 1697-1702.
11. Bryant H, Brasher P. Breast implant and breast cancer: Reanalysis of a linkage study. N Engl J Med. 1995;332:1535-1539.
12. Sanche-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speitzer FE, Liang MH. Silicone breast implants and the risk of connective tissue diseases and symptoms. N Engl J Med. 1995;332:1666-1670.
13. Brinton LA, Malone KE, Coates RJ, et al. Breast enlargement and reduction: Results from a breast cancer case-control study. Plast Reconstr Surg. 1996;97:269-275.
14. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998;19:61-109.
15. Nabel EG. The Women's Health Initiative. Science 2006;313: 1703.
16. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992;30:473-483.
17. Erkman LF, Syme SL. Social networks, host resistance, and mortality: A nine-year follow-up study of Alameda County residents. Am J Epidemiol. 1979;109:186-204.
18. Ruberman W, Weinblatt E, Goldberg JD, Chaudhary BS. Psychosocial influences on mortality after myocardial infarction. N Engl J Med. 1984;311:552-559.
19. Matthews KA, Shumaker SA, Bowen DJ, et al. Women's Health Initiative: Why now? What is it? What's new? Am Psychol. 1997;52:101-116.
20. King LA, Emmons RA. Psychological, physical, and interpersonal correlates of emotional expressiveness, conflict, and control. Eur J Pers. 1991;5:131-150.
21. Michael YL, Perrin N, Bowen D, et al. Expression and ambivalence over expression of negative emotion: Psychometric analysis in the Women's Health Initiative. J Women Aging 2005;17:5-18.
22. Cook W, Medley D. Proposed hostility and Pharisaic-virtue scales for the MMPI. J Appl Psychol. 1954;38:414-418.
23. Scheier MF, Carver CS, Bridges MW. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. J Pers Soc Psychol. 1994;67:1063-1078.
24. Levine DW, Kaplan RM, Kripke DF, Bowen DJ, Naughton MJ, Shumaker SA. Factor structure and measurement invariance of the Women's Health Initiative Insomnia Rating Scale. Psychol Assess. 2003;15:123-136.
25. Rook KS. The negative side of social interaction: Impact on psychological well-being. J Pers Soc Psychol. 1984;46:1097-1108.
26. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32:705-714.
27. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA. 1995;273:199-208.
28. Burnam MA, Wells KB, Leake B, Landsverk J. Development of a brief screening instrument for detecting depressive disorders. Med Care 1988;26:775-789.
29. Walitt BT, Constantinescu F, Katz JD, et al. Validation of self-report of rheumatoid arthritis and systemic lupus erythematosus: The Women's Health Initiative. J Rheumatol. 2008;35:811-818.
30. McLaughlin JK, Lipworth L, Fryzek JP, Ye W, Tarone RE, Nyren O. Long-term cancer risk among Swedish women with cosmetic breast implants: An update of a nationwide study. J Natl Cancer Inst. 2006;98:557-560.
31. Sarwer DB, Wadden TA, Whitaker LA. An investigation of changes in body image following cosmetic surgery. Plast Reconstr Surg. 2002;109:363-369.
32. Rankin M, Borah GL, Perry AW, Way PD. Quality-of-life outcomes after cosmetic surgery. Plast Reconstr Surg. 1998; 102:2139-2145.
33. Kjoller K, Friism S, Mellenkjaer L, et al. Connective tissue disease and other rheumatic conditions following cosmetic breast implantation in Denmark. Arch Intern Med. 2001;161: 973-979.
34. Sarwer DB, Nordmann JE, Herbert JD. Cosmetic breast augmentation surgery: A critical overview. J Womens Health Gend Based Med. 2000;9:843-856.
35. McLaughlin JK, Wise TN, Lipworth L. Increased risk of suicide among patients with breast implants: Do the epidemiologic data support psychiatric consultation? Psychosomatics 2004;45:277-280.
36. Omalu BI, Cho P, Shakir AM, et al. Suicides following bariatric surgery for the treatment of obesity. Surg Obes Relat Dis. 2005;1:447-449.
37. Fryzek JP, Signorello LB, Hakelius L, et al. Self-reported symptoms among cosmetic breast implant and breast reduction surgery. Plast Reconstr Surg. 2001;107:206-213.
38. Kjoller K, Holmich LR, Jacobesen PH, et al. Epidemiological investigation of local complications after cosmetic breast implant surgery in Denmark. Ann Plast Surg. 2002;48:229-237.
39. Henriksen TF, Homlich LR, Fryzek JP, et al. Incidence and severity of short-term complications after breast augmentation: Results from a nationwide breast implant registry. Ann Plast Surg. 2003;51:531-539.
40. Deapen DM, Pike MC, Casagrande JT, Brody GS. The relationship between breast cancer and augmentation mammaplasty: An epidemiologic study. Plast Reconstr Surg. 1986;77: 361-368.
41. Deapen DM, Bernstein L, Brody GS. Are breast implants anticarcinogenic? A 14 year follow-up of the Los Angeles study. Plast Reconstr Surg. 1997;99:1346-1353.
42. Brisson J, Holowaty EJ, Villeneuve PJ, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer 2006;118:2854-2862.
43. Berkel H, Birdsell DC, Jenkins H. Breast augmentation: A risk factor for breast cancer? N Engl J Med. 1992;326:1649-1653.
44. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN. Breast cancer following augmentation mammaplasty (United States). Cancer Causes Control. 2000;11:819-927.
45. Friis S, McLaughlin JK, Mellemkjaer L, et al. Breast implants and cancer risk in Denmark. Int J Cancer 1997;71:956-958.